North Carolina is one of the few states offering a unique, comprehensive environment for biotechnology firms where entrepreneurs can take an idea conceived in a laboratory, refine the product, produce and test it through the clinical trial phases and manufacture and distribute to global markets.
North Carolina has the third largest biotechnology industry in the nation with nearly 450 bioscience companies, contract research organizations and device and life science-related companies. More than 55,000 workers, with skill sets ranging from bioprocess technicians to Ph.Ds including some are employed by this sector. Among the state’s largest biotech and pharmaceutical firms are GlaxoSmithKline, Merck, Bayer, Biogen IDEC, Diosynth, Novo Nordisk, Wyeth and Baxter.
To help meet the industry’s ongoing need for trained professionals, we have created the country’s first comprehensive biotechnology training program that partners industry, government and academia through the North Carolina Biosciences Organization.
For more information, download the 
North Carolina Biotechnology, Pharmaceutical and Life Sciences Brochure.